Bispecific T-cell engager therapy for multiple myeloma

Best Practice and Research: Clinical Haematology · Published 2025-08-05 · DOI 10.1016/j.beha.2025.101649

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.beha.2025.101649

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease · Best Practice and Research: Clinical Haematology · 2024 · Same journal
• Shape of the art: TCR-repertoire after allogeneic hematopoietic cell transplantation · Best Practice and Research: Clinical Haematology · 2024 · Same journal
• HLA typing: A review of methodologies and clinical impact on haematopoietic cell transplantation · Best Practice and Research: Clinical Haematology · 2024 · Same journal
• Cytokines in transplantation tolerance · Best Practice and Research: Clinical Haematology · 2025 · Same journal
• The most frequent HLA alleles around the world: A fundamental synopsis · Best Practice and Research: Clinical Haematology · 2024 · Same journal
• Mesenchymal stem cells in hematology: Therapeutic initiatives and future directions · Best Practice and Research: Clinical Haematology · 2025 · Same journal
• Progress and challenges in the acute leukemia field · Best Practice and Research: Clinical Haematology · 2023 · Same journal
• Adoptive cellular therapies in non-Hodgkin lymphomas · Best Practice and Research: Clinical Haematology · 2025 · Same journal
• Minor histocompatibility antigens to predict, monitor or manipulate GvL and GvHD after allogeneic hematopoietic cell transplantation · Best Practice and Research: Clinical Haematology · 2024 · Same journal
• Cytogenetics and genomics in CML and other myeloproliferative neoplasms · Best Practice and Research: Clinical Haematology · 2024 · Same journal